Spectral Medical Inc T.EDT

Alternate Symbol(s): EDTXF

Spectral Medical Inc. is a Canada-based late-stage theragnostic company advancing therapeutic options for sepsis and septic shock. The Company develops and commercializes a treatment for septic shock utilizing its Endotoxin Activity Assay (EAA) diagnostic and the Toraymyxin therapeutic (PMX). PMX is a therapeutic hemoperfusion device that removes endotoxin, which can cause sepsis, from the bloodstream and is guided by the Company’s EAA. PMX is approved for therapeutic use in Japan and Europe and has been used safely and effectively on more than 340,000 patients to date. It has pioneered the development of biochemical markers for the clinical syndrome known as septic shock. It is continuing its legacy business of manufacturing and selling certain proprietary reagents. It develops, produces and markets recombinant proteins, antibodies and calibrators. These materials are sold for use in research and development, as well as in products manufactured by other diagnostic companies.

TSX:EDT - Post by User

Spectral Medical Inc > Baxter Redaction Reveal?

<< Previous

Bullboard Posts

Next >>

Comment by mercedesmanon Feb 21, 2024 9:19am

147 Views

Post# 35890565

RE:RE:RE:Baxter Redaction Reveal?

"I'm dying to see the mortality benefit"
lol. I see what you did there.

The PMX recipients are not dying to be a part of the mortality stats. And the number of spam filter recipients dying, vis-a-vis the others, is exceeding expectations. Apologies for that bit of crude data humour.

I suspect we'll get some "read between the fine line" assurances - much like we have already have in the past, only maybe just a more. Dawn will reveal the whole puzzle.

MM